Rituximab biosimilars: introduction into clinical practice

被引：2
|
作者：
Makita, Shinichi [1 ]
Tobinai, Kensei [1 ]
机构：
[1] Natl Canc Ctr, Dept Hematol, Chuo Ku, Tokyo 1040045, Japan
来源：
LANCET HAEMATOLOGY | 2017年 / 4卷 / 08期
关键词：
LYMPHOMA;
D O I：
10.1016/S2352-3026(17)30124-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E342 / E343
页数：2
相关论文
共 50 条
  • [1] Rituximab biosimilars in clinical practice
    Jurczak, Wojciech
    Dlugosz-Danecka, Monika
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1523 - 1524
  • [2] Biosimilars in clinical practice
    Mikhail, Ashraf
    KIDNEY & BLOOD PRESSURE RESEARCH, 2007, 30 : 18 - 22
  • [3] Rituximab biosimilars
    Vital, Edward M.
    Kay, Jonathan
    Emery, Paul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (07) : 1049 - 1062
  • [4] THE PLACE OF BIOSIMILARS IN CLINICAL PRACTICE
    Taylor, Peter
    RHEUMATOLOGY, 2014, 53 : 6 - 6
  • [5] Biosimilars: Implications for Clinical Practice
    Rifkin, Robert M.
    Peck, Susan R.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (09) : 24S - +
  • [6] Fostering the Adoption of Biosimilars Into Clinical Practice
    Terrie, Yvette C.
    US PHARMACIST, 2023, 48 (06) : 36 - 41
  • [7] Insulin biobetters and biosimilars in clinical practice
    Home, Philip
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2023, 53 (02): : 147 - 155
  • [8] Potential problems of biosimilars in clinical practice
    Korucu, Fatma Ceyda
    Nazli, Hakan
    Gedik, Gulsah
    Cicin, Irfan
    MARMARA PHARMACEUTICAL JOURNAL, 2016, 20 (01) : 44 - 51
  • [9] Inflammatory diseases: Integrating biosimilars into clinical practice
    Feldman, Steven R.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (06) : S16 - S21
  • [10] Biosimilars in Oncology: From Development to Clinical Practice
    Tkaczuk, Katherine H. Rak
    Jacobs, Ira Allen
    SEMINARS IN ONCOLOGY, 2014, 41 (02) : S3 - S12
12345